WallStreetZenWallStreetZen

NASDAQ: AVTE
Aerovate Therapeutics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Aerovate Therapeutics earnings were -$49.0M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest AVTE earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$2.5M, down 53.6% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, AVTE reported annual earnings of -$69.6M, with -7.8% growth.

AVTE earnings history

Current Revenue
$0.0
Current Earnings
-$49.0M
Current Profit Margin
0%

AVTE Return on Equity

Current Company
-60%
Current Industry
1.9%
Current Market
25%
AVTE's Return on Equity (-60%)... subscribe to Premium to read more.
High Return on Equity Performance

AVTE undefined

Current Company
-54.3%
Current Industry
0.9%
AVTE is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when AVTE announces earnings.

AVTE undefined

Current Company
-65.11%
Current Industry
3.6%
AVTE's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

AVTE vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
AVTE-$48.65M-$48.96MN/A-$1.70
CNTX-$26.67M-$26.73MN/A-$0.46
UNCY-$36.23M-$37.82MN/A-$0.56
ELTX-$50.27M-$51.90MN/A-$4.25
NTRB-$10.14M-$10.48MN/A-$0.99
View Top Biotech Stocks

Aerovate Therapeutics Earnings Reports & History FAQ

What were Aerovate Therapeutics's earnings last quarter?

Aerovate Therapeutics (NASDAQ: AVTE) reported Q1 2025 earnings per share (EPS) of -$0.09, up 89.16% year over year. Total AVTE earnings for the quarter were -$2.52 million. In the same quarter last year, Aerovate Therapeutics's earnings per share (EPS) was -$0.83.

If you're new to stock investing, here's how to buy Aerovate Therapeutics stock.

Is Aerovate Therapeutics profitable or losing money?

As of the last Aerovate Therapeutics earnings report, Aerovate Therapeutics is currently losing money. Aerovate Therapeutics's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$48.96 million, a 40.43% decrease year over year.

What was AVTE's earnings growth in the past year?

As of Aerovate Therapeutics's earnings date in Q2 2025, Aerovate Therapeutics's earnings has grown year over year. AVTE earnings in the past year totalled -$48.96 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.